Eckardt K U
Department of Internal Medicine, University Clinic Rudolf Virchow, Berlin, Fed. Rep. of Germany.
J Perinat Med. 1995;23(1-2):19-29. doi: 10.1515/jpme.1995.23.1-2.19.
In has been long recognized that erythropoiesis in adults is under control of erythropoietin, a glycoprotein produced mainly by adult kidneys in inverse relation to oxygen availability. Increasing evidence indicates nowadays that EPO is also an essential growth factor for red cell precursors at different sites of fetal erythropoiesis. The primary site of EPO production during fetal and neonatal life is the liver, and the fetus has been shown to be able to increase EPO production in response to hypoxia through intrinsic oxygen sensing mechanisms of hepatocytes. Thus despite different sites of both erythropoiesis and EPO production a similar oxygen dependent feedback control of red cell formation appears to operate during all stages of development. EPO levels in fetal blood are potentially useful parameters of fetal stress, and, as in adults, the availability of recombinant EPO raises the possibility to modulate erythropoiesis in the perinatal period.
长期以来人们一直认识到,成人的红细胞生成受促红细胞生成素的控制,促红细胞生成素是一种主要由成人肾脏产生的糖蛋白,与氧气供应呈负相关。如今,越来越多的证据表明,促红细胞生成素也是胎儿红细胞生成不同部位红细胞前体的重要生长因子。胎儿和新生儿期促红细胞生成素产生的主要部位是肝脏,并且已经表明胎儿能够通过肝细胞的内在氧传感机制对缺氧作出反应,增加促红细胞生成素的产生。因此,尽管红细胞生成和促红细胞生成素产生的部位不同,但在发育的所有阶段,红细胞形成似乎都存在类似的氧依赖性反馈控制。胎儿血液中的促红细胞生成素水平可能是胎儿应激的有用参数,并且与成人一样,重组促红细胞生成素的可得性增加了在围产期调节红细胞生成的可能性。